Weakness in Avapro - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Weakness, when it was recovered, drug effectiveness, race, and more among people who take Avapro (irbesartan). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Avapro?

Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,613 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 28, 2026

16 people who have Weakness while taking Avapro were studied.

Severity of Weakness *:

least: 8.33 %
moderate: 66.67 %
severe: 8.33 %
most severe: 16.67 %

When people recovered from Weakness *:

while on drug: 12.5 %
after off the drug: 0.0 %
not yet: 87.5 %

Effectiveness of Avapro *:

not at all: 0.0 %
somewhat: 25 %
moderate: 25 %
high: 25 %
very high: 25 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 10 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 90 %

Time on Avapro *:

Gender of people when taking Avapro *:

female: 37.5 %
male: 62.5 %

Age of people when taking Avapro *:

Conditions people have *:

Depression: 4 people, 25.00%
Diabetes: 4 people, 25.00%
High Blood Cholesterol: 4 people, 25.00%
Essential Hypertension (primary hypertension): 3 people, 18.75%
Enlarged Prostate: 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
Type 1 Diabetes: 1 person, 6.25%
Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 1 person, 6.25%
Bone Density Decreased: 1 person, 6.25%
Fatigue (feeling of tiredness): 1 person, 6.25%

Other drugs people take besides Avapro *:

Other side effects people have besides Weakness *:

Dizziness: 5 people, 31.25%
Fatigue (feeling of tiredness): 5 people, 31.25%
Pain: 2 people, 12.50%
Back Pain: 2 people, 12.50%
Hair Loss: 2 people, 12.50%
Drowsiness: 2 people, 12.50%
Hepatic Steatosis (fatty liver disease): 1 person, 6.25%
Heart Rate Irregular: 1 person, 6.25%
Headache (pain in head): 1 person, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Avapro and have Weakness?

Check whether Weakness is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Weakness in Avapro

How the study uses the data?

The study is based on irbesartan (the active ingredients of Avapro). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.